This Pot Stock Climbed 8% Last Week While Others Were Crashing

Neptune Wellness Solutions Inc. (TSX:NEPT)(NASDAQ:NEPT) is a cannabis stock that has produced some great returns this year while also being able to avoid controversy and volatility along the way.

| More on:
little girl in pilot costume playing and dreaming of flying over the sky

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn moresdf

Concerns surrounding the safety of investing in the cannabis industry have recently come to the attention of investors. While pot stocks had a good month of January to start the year, they’ve struggled since then. With reports surrounding the possibility of write-downs coming for many companies and the recent CannTrust scandal, there are plenty of reasons why investors are spooked today. The pressure to deliver results has made it difficult for companies to be able to focus on growth while staying in line with regulations.

However, not everyone is happy with just growth anymore, as we saw the consequences of that earlier this month when Canopy Growth got rid of its Co-CEO Bruce Linton. The problem is that many of these new cannabis companies are just that – new.

Many have become too focused on trying to generate excitement and results rather than ensuring that processes are being followed and that they’re optimal. Costs have become secondary, which has led to some significant losses for cannabis companies along the way.

That’s why Neptune Wellness Solutions Inc. (TSX:NEPT)(NASDAQ:NEPT) might be one of the better plays that cannabis investors can make today. The company has been around for two decades and has a great deal of experience in producing wellness products.

With that experience comes an important attention to detail that’s necessary for long-term success in the cannabis industry in order to ensure that a company does not run afoul with a regulator like Health Canada.

It may come as no coincidence that as many cannabis companies saw their stocks fall last week, Neptune was going in the opposite direction. As a more established company, Neptune has more of a track record that investors can rely on. And while it too has struggled with profitability over the years, investors might feel that with Neptune, there’s less risk, as the company has demonstrated its ability to grow responsibly.

NEPT Price Chart

Trust is a big issue in the industry

After CannTrust investors got burned badly from the stock’s shocking losses last week, the issue of trust has become very important in the industry. One of the dangers of investing in cannabis over the past few years is that any news, good or bad, could have a significant impact on a stock, much more than even its financial performance.

Neptune has done a good job of staying out of the press for the wrong reasons and while that doesn’t offer any assurances for the future, it does give investors a more trust in the company than they would in others.

As the stock is a bit more under the radar and not as big of a name as others in the industry, it’s in a good position to succeed if it can continue to build on recent results and improve its prospects for profitability. Neptune is by no means a slam dunk for investors, as there are still questions about its ability to turn a profit and the stock certainly isn’t cheap, trading at more than seven times its book value.

However, relative to other cannabis stocks, it might be one of the safest growth plays for investors to make today in the industry.

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor David Jagielski has no position in any of the stocks mentioned.

More on Cannabis Stocks

Cannabis smoke
Cannabis Stocks

Canopy Growth Stock: Is Now a Good Time to Invest?

The road ahead is highly uncertain for Canopy Growth, as the stock is plagued with losses and seemingly unsurmountable industry…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

TLRY Stock: Should You Invest Now?

TLRY is a Canadian cannabis stock which is trading 91% below record highs. Let's see if you should own TLRY…

Read more »

Cannabis grows at a commercial farm.
Cannabis Stocks

Is Tilray Stock a Buy in February 2023?

Despite the volatile cannabis sector, Tilray could be a superb buy for long-term investors.

Read more »

Young woman sat at laptop by a window
Cannabis Stocks

Is SNDL Stock a Buy in February 2023?

SNDL is a beaten-down cannabis stock. While its revenue growth is exceptional, a weak balance sheet has driven stock prices…

Read more »

A cannabis plant grows.
Cannabis Stocks

TLRY Stock: Here’s What’s Coming in 2023

Tilray Inc. (TSX:TLRY) is geared up for big growth this decade and looks like one of the top cannabis stocks…

Read more »

A person holds a small glass jar of marijuana.
Cannabis Stocks

Canopy Growth Stock: Here’s What’s Coming in 2023

Canopy Growth stock has made a lot of new moves in the last few months, but where is the company…

Read more »

A cannabis plant grows.
Cannabis Stocks

Better Cannabis Buy: Canopy Growth Stock or Tilray?

Only two TSX weed stocks can deliver substantial returns in the highly anticipated growth of the global cannabis market.

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

Is Tilray Stock a Buy in January 2023?

Tilray stock has lost 50% of its value in the last 12 months, in line with its peers.

Read more »